Map My Customers

MARCH 31, 2022

As a pharmaceutical sales rep, there are appointments and meetings with doctors and professionals that need to stay up to date with the latest pharmacology treatment options for their patients. Pharmaceutical sales representatives will be the face of the company for drug and treatment manufacturers.

Medical sales reps 52

Medical sales reps Medical sales Sales Medical 52

Pharmaceutical Technology

FEBRUARY 16, 2023

Merck will be responsible for leading the preclinical pharmacology and biology trials. Earlier this month, Merck reported $13.83bn worldwide sales , representing a 2% increase in the fourth quarter (Q4) of 2022 from $13.52bn in the previous year’s quarter.

Pharmacology 59

Pharmacology Sales Leads Medical 59

Pharmaceutical Technology

FEBRUARY 8, 2023

In 2022, 54% of FDA new drug approvals were for rare diseases , a significant increase in proportion of approvals in the recent years. Blank acknowledged that in many cases, an exclusively paediatric patient population could lead to difficulties with drawing consent for early phase trials.

FDA 105

FDA Patients Pharmacology Pharmaceutical 105

European Pharmaceutical Review

DECEMBER 11, 2023

Known linkers in the RNA field are used to bond together the two pharmacologically active molecular entities and can be applied to multiple oligonucleotide modalities. Research advances are also helping us learn more about how RNA is processed, potentially leading to new strategies to alter dysfunctional RNA. cited 2023July].

Safety 98

Safety Pharmacology Engineering Medical 98

Impetus Digital

AUGUST 2, 2024

In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%. In turn, this can support decision-making and lead to more efficient inventory management and faster delivery times, enhance supply chain visibility and transparency, and avoid overproduction and waste.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

European Pharmaceutical Review

JULY 18, 2024

She leads Ipsen’s Early Development Portfolio across the company’s three therapeutic focus areas (Oncology, Rare Disease and Neuroscience). This covers nonclinical drug safety, translational and clinical pharmacology, drug metabolism and pharmacokinetics (DMPK) and pharmacometrics. 2022; 7(93) Maecker et al.

Food and Drug Administration 59

Food and Drug Administration Engineering Pharmacology Side effects 59

European Pharmaceutical Review

JANUARY 31, 2025

Over 100 biosimilar medicines are approved for nearly 30 reference medicines, testimony to the rigour of the scientific standards leading to the European authorisation process. These reconsiderations lead the way to liberating untapped potential from biological standards of care. She holds a MSc in Pharmacology. References 1.

Medicine 52

Medicine Competition Marketing Patients 52

Legacy MEDSearch

AUGUST 25, 2022

Early non-randomized European studies have suggested that this leads to reduced incidence of coronary microvascular obstruction (MVO) [3,4] and smaller infarct size, which are both strongly correlated to improvement in heart failure hospitalizations and reduced mortality following primary PCI [5]. said Olivier Delporte, CEO.

Medical 52

Medical FDA Recruitment Pharmacology 52

European Pharmaceutical Review

JULY 4, 2024

Prior to joining Fieldfisher, Taly spent four years working as in-house counsel for a leading tech company helping launch products across multiple EU markets. 2022 [cited 2024May]. She obtained a degree in physics from MIT prior to attending University of Pennsylvania Law School. researchspace.auckland.ac.nz.

Marketing 103

Marketing Food and Drug Administration Medicine Prescription 103

European Pharmaceutical Review

JANUARY 13, 2025

Research shows that the overall carbon emissions of the biotechnology sector globally totalled 193 million tCO2-e (tonnes of carbon dioxide equivalent) in 2022. Research demonstrates that the greenest inhaler is the one that is used and that leads to disease control. Pulmonary Pharmacology & Therapeutics. NHS England.

Medicine 52

Medicine Pharmaceutical Government Manufacturing 52

pharmaphorum

JANUARY 26, 2023

2022 was a banner year for genomics. A 2022 study from the Royal College of Physicians and British Pharmacological Society demonstrated the potential of pharmacogenomics, with scientists identifying the genetic cause behind an individual’s drug response for over forty medicines.

Pharmacology 130

Pharmacology Leads Government Physicians 130

European Pharmaceutical Review

SEPTEMBER 29, 2022

Most ISRs were mild to moderate in severity and none lead to premature discontinuation from the study. There were no life threatening TEAEs, TEAEs leading to premature discontinuation of study, serious adverse events (SAEs) or deaths. PPD is an extremely common psychological condition affecting women after labour.

Pharmacology 105

Pharmacology Leads Patients Management 105

Pharmaceutical Technology

AUGUST 8, 2022

The digital pill, now marketed by Otsuka Pharmaceuticals, is forecasted to make $27 million in sales in 2022, as per GlobalData. These days, he is leading trials involving a system developed by the digital health company etectRx (pronounced as e-tect-are-ex), which works with investigators who can use such real-time data.

Food and Drug Administration 122

Food and Drug Administration FDA Medicine Patients 122

European Pharmaceutical Review

MAY 2, 2023

Cancer remains a global threat with around 10 million people dying from the disease each year worldwide, making it the second leading cause of death. billion in 2022, the average projected return on investment (ROI) in R&D was just 1.2 1,2 In the EU, an estimated 2.7 Available from: [link] Worldwide cancer statistics [Internet].

Patients 105

Patients Medicine Marketing Medical 105

European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. 2022 Alzheimer’s Association International Conference. months for donanemab.

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97

pharmaphorum

JANUARY 16, 2023

Last year, IQVIA predicted that 2022 would be the crunch year for Alzheimer’s therapies: it is with a sense of déjà vu that the exact same prediction is contemplated for 2023. Alzheimer’s is currently the seventh-leading cause of death globally and growing fast. Innovation will power the market.

FDA 98

FDA Healthcare Healthcare Medicine 98

Pharmaceutical Technology

NOVEMBER 3, 2022

There, Boehringer had earlier warned of the impending alteplase shortage in April 2022. This is due to aging populations around the world, which leads to an increased risk of such conditions, explains Craig Beavers, PhD, assistant professor at the University of Kentucky’s College of Pharmacy in Lexington.

Medicine 111

Medicine Manufacturing Pharmacology Healthcare 111